GlassScriptPhysician profile
David James Maron
NPI 1912937913
$12,180.62
in general payments reported to CMS, 2019-2025
11 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,224 · 2020: $699 · 2021: $150 · 2022: $6,583 · 2023: $285 · 2024: $779 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990 · Travel and Lodging: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.38 |
| Travel and Lodging | $534.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,245.40 | 2019-2024 | |
| Cipla USA INC. | $2,966.60 | 2019 | |
| Medtronic, INC. | $1,306.30 | 2022-2025 | Signia, Ligasure, Interstim |
| Covidien LP | $855.72 | 2019-2020 | |
| Ethicon US, LLC | $238.63 | 2022-2023 | Monocryl, Echelon Circular |
| Innovation Technologies INC | $228.92 | 2024-2025 | Irrisept |
| Abbvie INC. | $155.85 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $141.92 | 2024 | |
| Janssen Biotech, INC. | $24.60 | 2025 | Tremfya |
| Conmed Corporation | $16.68 | 2025 | Airseal |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Maron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.